Ποια είναι η τιμή για IXensor Co., Ltd. (6734)

Η τιμή για IXensor Co., Ltd. (6734) είναι $0.20383177

Ποια είναι η κεφαλαιοποίηση αγοράς για IXensor Co., Ltd. (6734)

Η κεφαλαιοποίηση αγοράς για IXensor Co., Ltd. (6734) είναι $8.46M

IXensor Co., Ltd. (6734) Τιμή και Κεφαλαιοποίηση Αγοράς

iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.

Η τιμή για 6734	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$131,283 $8.46M	NVDA	$5.452T	+64,407,393.11%
$108,121 $8.46M	AAPL	$4.490T	+53,044,279.88%
$100,399 $8.46M	GOOG	$4.169T	+49,255,635.43%
$88,527.65 $8.46M	MSFT	$3.676T	+43,431,621.37%
$68,220.68 $8.46M	AMZN	$2.833T	+33,469,012.30%

Η τιμή για 6734

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$131,283 $8.46M